Long-term erythropoietin in rats with reduced renal mass

Nephron

Volumn 73, Issue 2, 1996, Pages 280-285

  Torralbo, Antonio ^a   Blanco, Julia ^a   Fontanellas, Antonio ^a   Herrero, José Antonio ^a   Cruceyra, Antonio ^a   Gonzâlez Lôpez, Pablo ^a   Barrientos, Alberto ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Arterial hypertension; Chronic renal failure; Erythropoietin

Indexed keywords

ANTIANEMIC AGENT; ANTIHYPERTENSIVE AGENT; ENALAPRIL; RECOMBINANT ERYTHROPOIETIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; GLOMERULOSCLEROSIS; HEMATOCRIT; HYPERTENSION; LONG TERM CARE; MALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROTEINURIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR DISEASE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; CREATININE; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; KIDNEY; MALE; NEPHRECTOMY; PROTEINURIA; RATS; RATS, WISTAR; VASODILATION;

EID: 0029997040     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189052     Document Type: Article

References (17)

1. Gretz N, Lasserrc JJ, Mcisingcr E. Strauch M. Waldherr R. Kraft K. W'cidler A: Potential sidc-effects of erythropoietin (letter). Lancet 1987;i:46.
2. Eschbach JW. Abdulhadi MH. Browne JK. Delano BG. Downing MR. Egric JC. Evans RW. Friedman EA. Graber SE. Haley NR. Korbet S. Krantz SB. Lundin AP. Nissenson AR. Ogden DA. Paganini EP. Rader B. Rutsky EA. Stivcl-man J. Stone WJ. Teschan P, Van Stone JC, Van Wyck DB. Zuckcrman K. Adamson JW: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989:111:992-1000.
3. Eschbach JW', Kelly MR. Haley NR. Abels RI, Adamson JW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989:321:158-163.
4. Wilson C. Byrom FB: Renal changes in malignant hypertension. Lancet 1939;i: 136-138.
5. Myers BD. Deen WM. Robertson CR. Brenner BM: Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit. Circ Res 1975:36:425-435.
6. Anagnostou A, Sun Lee E. Kcssimian N. Levinson R. Steiner M: Erythropoietin has a mito-gcnic and positive chcmotactic effect on endothelial cells. Proc Natl Acad Sei USA 1990:87: 5978-5982.
7. Garcia DL. Anderson S. Rennke HG. Brenner BM: Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats w ith reduced renal mass. Proc Natl Acad Sei USA 1988:85:6142-6146.
8. Ruedin P. Lemoine R. Bouillie M. Leski M. Kanfcr A: Prevention of accelerated renal failure induced by rcvombinant human erythropoietin in the rat remnant kidney (abstract). Nephrol Dial Transplant 1991:6:828.
9. Chanutin A. Ferris EP: Experimental renal insufficiency produced by partial nephrectomy. Arch Intern Med 1932:49:767-787.
10. Coleman TG: Hemodynamics of uremic anemia. Circulation 1972:45:510-511.
11. Simpson LO: Blood viscosity induced proteinuria. Nephron 1984:36:280-281.
12. Sklar AH. Chaundary BA: Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med 1988:148:87-89.
13. Metcalf D: Peptide regulatory factors. Haemo-poictic growth factors. 1. Lancet 1989:i:825-827.
14. Yoshida Y. Kawamura T. lkoma M. Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36:626-635.
15. Jackson B. Johnston Cl: The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: Effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 1988:6:495-501.
16. Eggena P. Willscy P. Jamgotchian N, Trucken-brod L. Hu MS. Barrett JD. Eggena MP. Clegg K. Nakhoul F. Lee BN: Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems. Am J Physiol 1991;26 LE642-E646.
17. Carlini RG. Dusso AS. Obialo CL Alvarez UM. Rothstcin M: Recombinant human erythropoietin (RHuEPO) increasescndothelin-l release by endothelial cells. Kidney Int 1993:43: 1010-1014.